A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.


Updates from The Motley Fool

Latest updates on Threshold Pharmaceuticals from Fool.com.
3 Stocks to Get on Your Watchlist

I follow a lot of companies, so the usefulness of a watchlist cannot be overstated. Without my wa...

Is Threshold on the Threshold?

The last time that  Threshold Pharmaceuticals ( Nasdaq: THLD     ) announced phase 2 study res...

3 Big Biotech Trial Results

When trial results come in for a company in the health care space, it's often do or die, make or ...

3 Biotechs With Good FDA News

Today's health care headlines are dominated by earnings from two of the sector's biggest players:...

Why Did My Stock Just Die?

Earnings season begins anew and doubts about the strength of the economy still filter through exp...



Stock Performance

View Interactive THLD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Threshold Pharmaceuticals.
Current Price: $0.47
Prev Close: $0.48
Open: $0.49
Bid: $0.47
Ask: $0.47
Day's Range: $0.45 - $0.49
52wk Range: $0.21 - $3.43
Volume: 263,043
Avg Vol 902,484
Market Cap: $34M
P/E (ttm): 0.30
EPS (ttm): $1.58
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Threshold Pharmaceuticals.
CAPS Rating 3 out of 5
 
118 Outperform
19 Underperform
CAPS All Stars
 
25 Outperform
3 Underperform

How do you think Threshold Pharmaceuticals will perform against the market?



You pick for Threshold Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Barry Selick, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Threshold Pharmaceuticals.

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers